上海交通大学科研成果转化,以人工智能为基础的生物科技公司。肿瘤和免疫学方向为主的复杂疾病早期筛查诊断和治疗,主要管线为治疗型癌症新抗原mRNA疫苗。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows